Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailin Chen

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cell Death Discovery|March 5, 2026
Absolute dynamic and relative static: the relationship of glycolysis and OXPHOS in cancer developmentXingting Bao, Boru Hou, Zhong Guo, et al.
Optics Express|December 19, 2025
Design of ultrawideband metamaterial absorber with enhanced optical transparency utilizing laser etching ITO micromeshKaitao Wang, Jie Li, Xu Han, et al.
Toxicology and Applied Pharmacology|July 31, 2012
Novel bis-(-)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing propertyWei Zheng, Juan Li, Zhuibai Qiu, et al.
BMC Veterinary Research|July 5, 2025
Isolation and characterization of Pseudomonas phage HJ01 and its therapeutic efficacy in canine pyodermaYixian Wei, Ziyong Li, Jianlong Lao, et al.
Blood Cancer Journal|August 16, 2022
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiationHailin Chen, Tengteng Yu, Liang Lin, et al.
Journal of Translational Medicine|September 11, 2021
Platelet transcriptome profiles provide potential therapeutic targets for elderly acute myelocytic leukemia patientsJizhang Bao, Xinhua Zhao, Jiahui Lu, et al.
Leukemia|July 8, 2020
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myelomaLiang Lin, Shih-Feng Cho, Lijie Xing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 ExpressionLijie Xing, Su Wang, Jiye Liu, et al.
Genome Medicine|January 14, 2017
ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variantsRonak Y Patel, Neethu Shah, Andrew R Jackson, et al.
Blood Cancer Journal|November 5, 2020
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivoTengteng Yu, Bharat Chaganty, Liang Lin, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cell Death Discovery|March 5, 2026
Absolute dynamic and relative static: the relationship of glycolysis and OXPHOS in cancer developmentXingting Bao, Boru Hou, Zhong Guo, et al.
Optics Express|December 19, 2025
Design of ultrawideband metamaterial absorber with enhanced optical transparency utilizing laser etching ITO micromeshKaitao Wang, Jie Li, Xu Han, et al.
Toxicology and Applied Pharmacology|July 31, 2012
Novel bis-(-)-nor-meptazinol derivatives act as dual binding site AChE inhibitors with metal-complexing propertyWei Zheng, Juan Li, Zhuibai Qiu, et al.
BMC Veterinary Research|July 5, 2025
Isolation and characterization of Pseudomonas phage HJ01 and its therapeutic efficacy in canine pyodermaYixian Wei, Ziyong Li, Jianlong Lao, et al.
Blood Cancer Journal|August 16, 2022
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiationHailin Chen, Tengteng Yu, Liang Lin, et al.
Journal of Translational Medicine|September 11, 2021
Platelet transcriptome profiles provide potential therapeutic targets for elderly acute myelocytic leukemia patientsJizhang Bao, Xinhua Zhao, Jiahui Lu, et al.
Leukemia|July 8, 2020
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myelomaLiang Lin, Shih-Feng Cho, Lijie Xing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 ExpressionLijie Xing, Su Wang, Jiye Liu, et al.
Genome Medicine|January 14, 2017
ClinGen Pathogenicity Calculator: a configurable system for assessing pathogenicity of genetic variantsRonak Y Patel, Neethu Shah, Andrew R Jackson, et al.
Blood Cancer Journal|November 5, 2020
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivoTengteng Yu, Bharat Chaganty, Liang Lin, et al.
Pageof 8